Clinic
Modern Urgent Care INC.
Modern Urgent Care INC. was paid $14.48M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 19% of everything it billed.
33Billing provider infoMODERN URGENT CARE INC.
CERES, CA 95307
CERES, CA 95307
33aNPI1427441286assigned 03/17/2015
33bProvider typeUrgent Care Clinic/Center
28Total paid$14.48M
24GClaims415,483
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#15 of 284
Median peer was paid$147K
This provider vs. median98×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,715 | $1.61M | |
| 2019 | 48,900 | $1.42M | |
| 2020 | 41,367 | $1.69M | |
| 2021 | 91,660 | $3.11M | |
| 2022 | 67,178 | $2.36M | |
| 2023 | 55,153 | $2.10M | |
| 2024incomplete | 56,510 | $2.19M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 19% | 38,658 | 38,504 | $2.77M |
| 87428 | 18% | 34,294 | 31,845 | $2.58M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 50,366 | 46,214 | $2.46M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 58,590 | 53,435 | $1.76M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 41,455 | 38,145 | $1.63M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.2% | 38,887 | 35,732 | $753K |
| H0033 | Oral medication administration, direct observation | 3.0% | 19,773 | 18,702 | $428K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 2,568 | 2,369 | $277K |
| 86769 | 1.8% | 3,536 | 3,488 | $265K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 9,500 | 8,913 | $232K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 25,492 | 24,485 | $202K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 2,243 | 2,239 | $186K |
41 more codes
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 1.0% | 6,113 | $148K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,618 | $97K |
| 81000 | <1% | 25,664 | $75K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 998 | $73K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,484 | $56K |
| 94760 | <1% | 8,684 | $52K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,006 | $49K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,999 | $43K |
| 87807 | <1% | 4,241 | $42K | |
| 81025 | <1% | 12,861 | $41K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,410 | $30K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 606 | $28K |
| 99406 | <1% | 1,817 | $21K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 821 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 563 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 565 | $18K |
| D1206 | Topical application of fluoride varnish | <1% | 764 | $18K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 459 | $16K |
| 82948 | <1% | 4,476 | $14K | |
| 90686 | <1% | 600 | $12K | |
| 69210 | <1% | 338 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,348 | $10K |
| 90688 | <1% | 317 | $6K | |
| 86677 | <1% | 272 | $4K | |
| 87905 | <1% | 279 | $3K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 266 | $3K |
| 90674 | <1% | 135 | $3K | |
| 85018 | <1% | 1,144 | $3K | |
| 99173 | <1% | 862 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 60 | $2K |
| 86580 | <1% | 651 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 200 | $2K |
| 86308 | <1% | 292 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 34 | $1K |
| 29540 | <1% | 51 | $1K | |
| 90656 | <1% | 36 | $740.81 | |
| 90714 | <1% | 14 | $452.47 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $336.51 |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 17 | $315.16 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 30 | $222.61 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $157.78 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJHATU, HARINDER (PARTNER)